Oltipraz

DB12539InvestigationalSmall molecule

Oltipraz has been used in trials studying the treatment and prevention of Lung Cancer, Liver Fibrosis, Liver Cirrhosis, and Non-alcoholic Fatty Liver Disease.

Chemical structure of Oltipraz
Formula / weight
C8H6N2S3 · 226.342 g/mol (avg)

Resolves to

Compound
UNII6N510JUL1YCAS64224-21-1ChEMBLCHEMBL178459ChEBI77319PubChem47318
Structure
InChIKeyCKNAQFVBEHDJQV-UHFFFAOYSA-NSMILESCC1=C(SSC1=S)C1=CN=CC=N1
Targets
P21980TGM2

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Oltipraz, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In